ArticleIJU case reports2025

Pembrolizumab Plus Lenvatinib for Metastatic Renal Cell Carcinoma in a Patient on Hemodialysis.

Shimpei Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.